Oncologist-approved cancer information from the American Society of Clinical Oncology
Printer Friendly
Download PDF

What to Know: ASCO's Guideline on Chemotherapy for Stage IV Non-Small Cell Lung Cancer

September 2011

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) developed evidence-based recommendations on the treatment of stage IV non-small cell lung cancer. This guide for patients contains several recommendations, one of which was updated in September 2011.

Key Messages:

  • Chemotherapy for stage IV non-small cell lung cancer may lengthen a patient's life and improve his or her quality of life.
  • This patient guide discusses which drugs, and which combination of drugs, are best for patients with stage IV non-small cell lung cancer based on results from clinical trials. These recommendations depend on the patient and the type of treatment he or she has already received.
  • Talk with your doctor about your health and the treatment options that are best for you. Treatment of the symptoms and side effects from the cancer and cancer treatments is also an important part of your care.

© 2005-2012 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.